Payment Terms | T/T |
Supply Ability | negotiable |
Packaging Details | 40box/carton |
Storage | 2℃-30℃ |
Sample Type | Blood |
User | Professionals |
Accuracy | 94.67% (95% CI: 91.57%~97.77%). |
Certificate | CE ISO 13485 |
Key words | COVID-19 IgG IgM Antibody Rapid Test Kit Professional Use 25 Test |
OEM | OEM customized packing avaliable |
Formats | 25T/box 1T/box |
Brand Name | Aichek |
Model Number | COVID-19-G02001A |
Certification | CE |
Place of Origin | China |
View Detail Information
Explore similar products
COVID 19 IgM IgG Test Kit Rtk Antibody Test Kit 95% CI Accuracy
ISO 25pcs Antibody Self Test Kit OEM 15 Minute Rapid Test Near Me
3mm Strip IgM IgG Rapid Test Blood Antibody Rapid Test Kit
COVID-19 4mm Antibody Test Device Antibody Rapid Test Kit
Product Specification
Payment Terms | T/T | Supply Ability | negotiable |
Packaging Details | 40box/carton | Storage | 2℃-30℃ |
Sample Type | Blood | User | Professionals |
Accuracy | 94.67% (95% CI: 91.57%~97.77%). | Certificate | CE ISO 13485 |
Key words | COVID-19 IgG IgM Antibody Rapid Test Kit Professional Use 25 Test | OEM | OEM customized packing avaliable |
Formats | 25T/box 1T/box | Brand Name | Aichek |
Model Number | COVID-19-G02001A | Certification | CE |
Place of Origin | China | ||
High Light | 25 Packs Test Rapid IgG IgM ,IgG IgM Antibody Rapid Test Kit ,Antibody Rapid Test Kit ISO 13485 |
For professional and in vitro diagnostic use only.
Product Name |
Easy to operate for SARS-CoV-2 IgG IgM Antibody Rapid Test Kit |
Formats | Strip(3mm)Device(4mm) uncut sheet |
Place of Origen | China |
Specimen | Blood |
Read Time | 15 minutes |
Shelf life | 2 years |
Package | uncut sheet |
Storage | 2℃-30℃ |
[INTENDED USE]
The COVID-19 IgG/IgM Rapid Test device is a lateral flow chromatographic immunoassay for the qualitative detection of antibodies (IgG and IgM) to Novel coronavirus in human Whole Blood/Serum/Plasma. It provides an aid in the diagnosis of infection with Novel coronavirus.
[PERFORMANCE CHARACTERISTICS]
Accuracy
If a person suffered the novel coronaviruses, there are several stages before recovery, like window period, early stage, initial stage, mid-term, and later period. The window period continues 14 days, 3-7days mostly, and no antibody produced at this time. Early stage is about 1-7 days after onset, and the IgM antibody appears, but the concentration is too low to be detected. Initial stage is about 8-14 days after onset, the IgM antibody increases and the IgG antibody appears. Mid-term is about 15-39 days after onset, the IgM antibody decreases gradually and the IgG antibody peaks. The later period is about 1-2 months after onset, and IgM antibody could be detected hardly. Also, everyone is different because of the difference of people’s immune response. For example, the antibody concentration of older people is higher than younger significantly, and the antibody levels in Asymptomatic infected human body are low generally.
A side-by-side comparison was conducted using the Novel coronavirus IgG/IgM Rapid Test and RT-PCR. 200 clinical specimens from Professional Point of Care site were evaluated, 57 were positive and 143 negative. In order to consider the difference of antibody production in people after infection as much as possible, we conducted 10 trails respectively. Base on the results from the clinical studies, the statistical analysis was made as follows:
COVID-19 IgM: the average sensitivity is 81.83% (95% CI: 70.18%~92.58%), the average specificity is 93.93% (95% CI: 88.23%~99.62%) and the total accuracy is 90.67% (95% CI: 87.07%~94.26%).
COVID-19 IgG: the average sensitivity is 92.50% (95% CI: 87.65%~97.35%), the average specificity is 95.53% (95% CI: 92.01%~99.06%) and the total accuracy is 94.67% (95% CI: 91.57%~97.77%).
[SUMMARY]
The novel coronaviruses belong to the β genus. COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main manifestations include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.
Company Details
Business Type:
Manufacturer
Year Established:
2012
Total Annual:
500000-1000000
Employee Number:
150~200
Ecer Certification:
Active Member
Hangzhou Aichek Medical Technology Co.,Ltd Hangzhou Aichek Medical Technology Co.,Ltd is a high-tech company specialises in manufacturing rapid diagnostic and healthcare products. With five product lines of fertility, infectious diseases, cardiac marker, tumor marker and drug of... Hangzhou Aichek Medical Technology Co.,Ltd Hangzhou Aichek Medical Technology Co.,Ltd is a high-tech company specialises in manufacturing rapid diagnostic and healthcare products. With five product lines of fertility, infectious diseases, cardiac marker, tumor marker and drug of...
Get in touch with us
Leave a Message, we will call you back quickly!